Cargando…
An indicator of cancer: downregulation of Monoamine Oxidase-A in multiple organs and species
BACKGROUND: Identifying consistent changes in cellular function that occur in multiple types of cancer could revolutionize the way cancer is treated. Previous work has produced promising results such as the identification of p53. Recently drugs that affect serotonin reuptake were shown to reduce the...
Autores principales: | Rybaczyk, Leszek A, Bashaw, Meredith J, Pathak, Dorothy R, Huang, Kun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2311292/ https://www.ncbi.nlm.nih.gov/pubmed/18366702 http://dx.doi.org/10.1186/1471-2164-9-134 |
Ejemplares similares
-
An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology
por: Rybaczyk, Leszek A, et al.
Publicado: (2005) -
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015) -
ABUSE OF MONOAMINE OXIDASE INHIBITORS
por: Ananth, Jambur, et al.
Publicado: (1995) -
Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
por: Naoi, Makoto, et al.
Publicado: (2022) -
Amphetamine Derivatives as Monoamine Oxidase Inhibitors
por: Reyes-Parada, Miguel, et al.
Publicado: (2020)